NOVEL THERAPIES AND DIAGNOSTICS FOR USE IN TREATMENT OF PERIDONTAL DISEASES
NOVEL THERAPIES AND DIAGNOSTICS FOR USE IN TREATMENT OF PERIDONTAL DISEASES
批准号:
6238370
负责人:
J M GOODSON
金额:
$12.17万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-15 至 1999-04-30
关键词:
bone regeneration clinical trials computer program /software dental disorder chemotherapy dental disorder diagnosis disease /disorder model disease /disorder prevention /control dogs drug adverse effect electrical impedance glucans human subject human therapy evaluation insulinlike growth factor laboratory mouse laboratory rat monocyte neutrophil pathologic bone resorption periodontium disorder platelet derived growth factor polymers rheumatoid arthritis technetium
中文摘要
建议评价4种新疗法和2种诊断方法。
重生。刺激牙周再生的潜力
应用多肽生长因子,
成功完成牙周治疗但
残留的骨下袋。PDGF(血小板衍生生长因子)和IGF
(胰岛素衍生生长因子)将局部应用于牙齿
牙根和牙槽骨缺损。将通过裂口评价反应
与单独使用车辆相比。
免疫调节剂。原理验证研究将由"猪-
对两项安慰剂对照研究的分析,
系统性疾病正在通过新型疗法来治疗。这包括
对接受IL-1受体治疗的患者的调查
拮抗剂ANTRIL缓解类风湿性关节炎,第二组
患者接受中性粒细胞刺激碳水化合物治疗。
用倍他克丁治疗骨髓衰竭在每种情况下,
同时牙周病将确定和临床措施
评估治疗后的变化。此外,动物研究
计划在模型系统中检查这些代理的效果。
抗体对结垢的反应。抗体对结垢的反应将是
在两种类型的测试中进行了研究。一项研究旨在确定
如果与体液抗体相关的临床和微生物学效应
当在口腔中的其他部位缩放时,可以测量变化。一
第二项研究旨在确定是否广泛的鳞屑或疾病
活性位点可用于增强治疗和/或微生物活性
反应
抗体对结垢的反应。抗体对结垢的反应将是
在两种类型的测试中进行了研究。一项研究旨在确定
如果与体液抗体相关的临床和微生物学效应
当在口腔中的其他部位缩放时,可以测量变化。一
第二项研究的目的是确定是否广泛的疾病规模,
活性位点可用于增强治疗和/或微生物活性
反应
诊断。牙周袋的电阻抗将是
结合电子口袋的测试进行了调查
深度探测器,以确定在检测
袋状溃疡。计算机算法将被编写和测试,
开发获得牙周骨定量信息的方法
在最小条件下通过放射减影技术丢失
标准化,例如在常规临床实践中会发生的标准化。
英文摘要
It is proposed that 4 novel therapies and 2 diagnostics be evaluated.
Regeneration. The potential for stimulation of periodontal regeneration
with application of the polypeptide growth factors will be tested in
patients who have successfully completed periodontal therapy but have
residual infrabony pockets. PDGF (platelet derived growth factor) and IGF
(insulin derived growth factor) will be topically applied to the tooth
root and alveolar defect. The response will be evaluated by a split-mouth
comparison with application of the vehicle alone.
Immunomodulators. Proof of principle studies will be conducted by "piggy-
back" analysis of two placebo controlled studies in which patients with
systemic disease are being treated by new types of therapy. This includes
an investigation of patients who are being treated with the IL-1 receptor
antagonist ANTRIL to relieve rheumatoid arthritis and a second group of
patients being treated by the neutrophil stimulating carbohydrate.
Betafectin for bone marrow failure. In each case, a subpopulation with
coincident periodontal disease will be identified and clinical measures
of change following therapy evaluated. In addition, animal studies are
planned to examine the effect of these agents in model systems.
Antibody Response to Scaling. The antibody response to scaling will be
investigated in two types of tests. One study is designed to determine
if clinical and microbiological effects associated with humoral antibody
changes can be measured when sites are scaled elsewhere in the mouth. A
second study is designed to determine if extensive scaling or disease
active sites can be used to augment therapeutic and/or microbiologic
response.
Antibody Response to Scaling. The antibody response to scaling will be
investigated in two types of tests. One study is designed to determine
if clinical and microbiological effects associated with humoral antibody
changes can be measured when sites are scaled elsewhere in the mouth. A
second study is designed to determine if extensive scaling of disease
active sites can be used to augment therapeutic and/or microbiologic
response.
Diagnostic. Electrical impedance of the periodontal pocket will be
investigated in conjunction with the testing of an electronic pocket
depth probe to determine potential utility in detecting conditions of
pocket ulceration. Computer algorithms will be written and tested to
develop methods to obtain quantitative information on periodontal bone
loss by radiographic subtraction techniques under conditions of minimal
standardization such as would occur in routine clinical practice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL THERAPIES AND DIAGNOSTICS FOR USE IN TREATMENT OF PERIDONTAL DISEASES
-
批准号:6104695
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:J M GOODSON
-
依托单位:
NOVEL THERAPIES AND DIAGNOSTICS FOR USE IN TREATMENT OF PERIDONTAL DISEASES
-
批准号:5210083
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J M GOODSON
-
依托单位:--
海外基金